Aytu BioPharma Inc (AYTU)
1.54
-0.20
(-11.75%)
USD |
NASDAQ |
Nov 14, 16:00
1.54
0.00 (0.00%)
After-Hours: 19:54
Aytu BioPharma Profit Margin (Quarterly): -25.68% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -25.68% |
| March 31, 2024 | -16.05% |
| December 31, 2023 | -0.96% |
| September 30, 2023 | -36.74% |
| June 30, 2023 | -7.99% |
| March 31, 2023 | -31.67% |
| December 31, 2022 | -25.47% |
| September 30, 2022 | -2.53% |
| June 30, 2022 | -58.62% |
| March 31, 2022 | -220.2% |
| December 31, 2021 | -49.94% |
| September 30, 2021 | -127.2% |
| June 30, 2021 | -80.90% |
| March 31, 2021 | -188.8% |
| December 31, 2020 | -62.88% |
| September 30, 2020 | -31.85% |
| June 30, 2020 | -21.17% |
| March 31, 2020 | -65.38% |
| December 31, 2019 | -6.75% |
| September 30, 2019 | -342.3% |
| June 30, 2019 | -847.0% |
| March 31, 2019 | -189.1% |
| December 31, 2018 | -259.5% |
| September 30, 2018 | -240.7% |
| June 30, 2018 | 59.08% |
| Date | Value |
|---|---|
| March 31, 2018 | -464.2% |
| December 31, 2017 | -349.4% |
| September 30, 2017 | -394.5% |
| June 30, 2017 | -807.5% |
| March 31, 2017 | -583.5% |
| December 31, 2016 | -606.7% |
| September 30, 2016 | -820.1% |
| June 30, 2016 | -1.63K% |
| March 31, 2016 | -1.09K% |
| December 31, 2015 | -709.9% |
| September 30, 2015 | -467.0% |
| June 30, 2015 | -1.18K% |
| March 31, 2015 | -7.73K% |
| February 28, 2015 | |
| November 30, 2014 | |
| August 31, 2014 | |
| May 31, 2014 | -1.18K% |
| February 28, 2014 | |
| November 30, 2013 | |
| August 31, 2013 | |
| May 31, 2013 | -758.0% |
| February 28, 2013 | |
| November 30, 2012 | |
| August 31, 2012 | -1.03K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-220.2%
Minimum
Mar 2022
-0.96%
Maximum
Dec 2023
-55.83%
Average
-31.85%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| enVVeno Medical Corp | -- |
| Bristol-Myers Squibb Co | 10.18% |
| Telesis Bio Inc | -811.9% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.64% |
| Return on Assets | -12.23% |
| Return on Invested Capital | -32.57% |
| Gross Profit Margin (Quarterly) | 66.23% |
| Operating Margin (Quarterly) | -8.51% |
| Return on Net Operating Assets | -15.85% |